Collaboration Agreements in the Biotechnology Industry
1,166 Contracts & Agreements
- 4D Molecular Therapeutics Inc (3 contracts)
- ACADIA PHARMACEUTICALS INC (1)
- ACCELERON PHARMA INC (4)
- Acorda Therapeutics (2)
- Acumen Pharmaceuticals, Inc. (2)
- Adagio Therapeutics, Inc. (2)
- Adaptimmune Therapeutics PLC (5)
- Adhera Therapeutics, Inc. (1)
- ADURO BIOTECH, INC. (2)
- Advaxis, Inc. (4)
- Adverum Biotechnologies, Inc. (4)
- AGENUS INC (1)
- AGIOS PHARMACEUTICALS INC (1)
- Aimmune Therapeutics, Inc. (3)
- AKCEA THERAPEUTICS, INC. (5)
- Akebia Therapeutics, Inc. (3)
- Alector, Inc. (3)
- Alkermes plc. (4)
- Allogene Therapeutics, Inc. (5)
- Allovir, Inc. (1)
- ALNYLAM PHARMACEUTICALS, INC. (26)
- ALPINE IMMUNE SCIENCES, INC. (1)
- Amgen Inc. (16)
- AMICUS THERAPEUTICS, INC. (10)
- AmpliPhi Biosciences Corp (3)
- ANAPTYSBIO INC (5)
- ANAVEX LIFE SCIENCES CORP. (2)
- Anixa Biosciences Inc (6)
- Aptevo Therapeutics Inc. (6)
- Aptinyx Inc. (1)
- AQUINOX PHARMACEUTICALS, INC (2)
- Aravive, Inc. (1)
- ARCA biopharma, Inc. (12)
- Arcellx, Inc. (1)
- Arcturus Therapeutics Holdings Inc. (2)
- Arcus Biosciences, Inc. (3)
- Arcutis Biotherapeutics, Inc. (1)
- ARENA PHARMACEUTICALS INC (1)
- Aridis Pharmaceuticals, Inc. (1)
- ARROWHEAD PHARMACEUTICALS, INC. (4)
- Arsanis, Inc. (1)
- Artiva Biotherapeutics, Inc. (3)
- ASSEMBLY BIOSCIENCES, INC. (2)
- Atara Biotherapeutics, Inc. (4)
- Athenex, Inc. (1)
- ATHERSYS, INC (5)
- Atreca, Inc. (1)
- aTYR PHARMA INC (1)
- AVEO PHARMACEUTICALS INC (4)
- Avidity Biosciences, Inc. (2)
- BeiGene, Ltd. (6)
- BELLICUM PHARMACEUTICALS, INC (1)
- BICYCLE THERAPEUTICS Ltd (7)
- BioAtla, Inc. (3)
- BIOCEPT INC (7)
- Biohaven Pharmaceutical Holding Co Ltd. (1)
- BIOMARIN PHARMACEUTICAL INC (1)
- BioXcel Therapeutics, Inc. (1)
- bluebird bio, Inc. (4)
- Blueprint Medicines Corp (11)
- BridgeBio Pharma, Inc. (2)
- C4 Therapeutics, Inc. (3)
- CALADRIUS BIOSCIENCES, INC. (1)
- Calithera Biosciences, Inc. (1)
- CAPRICOR THERAPEUTICS, INC. (1)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
- Caribou Biosciences, Inc. (12)
- Castle Creek Biosciences, Inc. (3)
- CATALYST BIOSCIENCES, INC. (5)
- CATALYST PHARMACEUTICALS, INC. (1)
- Celldex Therapeutics, Inc. (4)
- Cellular Biomedicine Group, Inc. (1)
- Century Therapeutics, Inc. (7)
- Checkmate Pharmaceuticals, Inc. (1)
- Checkpoint Therapeutics, Inc. (2)
- ChemoCentryx, Inc. (2)
- CHIMERIX INC (1)
- Cibus Global, Ltd. (1)
- Cidara Therapeutics, Inc. (1)
- Clovis Oncology, Inc. (3)
- CM Life Sciences III Inc. (1)
- COMPASS Pathways plc (1)
- Conatus Pharmaceuticals Inc. (1)
- Consonance-HFW Acquisition Corp. (1)
- CONSTELLATION PHARMACEUTICALS INC (2)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- CRISPR Therapeutics AG (6)
- CTI BIOPHARMA CORP (2)
- Cue Biopharma, Inc. (14)
- Cullinan Oncology, LLC (3)
- CURIS INC (5)
- Cyclacel Pharmaceuticals, Inc. (4)
- CytoDyn Inc. (2)
- Cytokinetics, Incorporated (12)
- CytomX Therapeutics, Inc. (16)
- DBV Technologies S.A. (1)
- Decibel Therapeutics, Inc. (1)
- Denali Therapeutics Inc. (3)
- DiaMedica Therapeutics Inc. (1)
- Dicerna Pharmaceuticals Inc (7)
- Diffusion Pharmaceuticals Inc. (1)
- DYADIC INTERNATIONAL INC (2)
- Dynamics Special Purpose Corp. (3)
- DYNAVAX TECHNOLOGIES CORP (2)
- Eagle Pharmaceuticals, Inc. (1)
- Edge Therapeutics, Inc. (3)
- Editas Medicine, Inc. (4)
- Eiger BioPharmaceuticals, Inc. (3)
- Elevation Oncology, Inc. (3)
- Entrada Therapeutics, Inc. (4)
- ENZON PHARMACEUTICALS, INC. (8)
- Epizyme, Inc. (12)
- Equillium, Inc. (6)
- Esperion Therapeutics, Inc. (6)
- Evelo Biosciences, Inc. (1)
- Exelixis (46)
- EXICURE, INC. (2)
- FATE THERAPEUTICS INC (3)
- Fibrocell Science, Inc. (3)
- FIBROGEN INC (3)
- FIVE PRIME THERAPEUTICS INC (21)
- Flex Pharma, Inc. (1)
- Foghorn Therapeutics Inc. (1)
- Forma Therapeutics Holdings, Inc., (1)
- Forty Seven, Inc. (1)
- Frequency Therapeutics, Inc. (1)
- Fusion Pharmaceuticals Inc. (5)
- GALECTIN THERAPEUTICS INC (2)
- Generation Bio Co. (1)
- GENETHERA INC (1)
- GENOCEA BIOSCIENCES, INC. (1)
- Genprex, Inc. (2)
- Gilead Sciences (3)
- Global Blood Therapeutics, Inc. (1)
- GLYCOMIMETICS INC (1)
- Gritstone Oncology, Inc. (2)
- GTX INC (8)
- Harpoon Therapeutics, Inc. (6)
- Hillstream BioPharma Inc. (1)
- Homology Medicines, Inc. (6)
- HOOKIPA Pharma Inc. (2)
- HUMANIGEN, INC (1)
- iBio, Inc. (2)
- IDEAYA Biosciences, Inc. (12)
- IDERA PHARMACEUTICALS, INC. (6)
- IGM Biosciences, Inc. (1)
- Immix Biopharma, Inc. (1)
- IMMUNOGEN INC (8)
- IMMUNOMEDICS INC (3)
- Incyte (7)
- INOVIO PHARMACEUTICALS, INC. (7)
- Intellia Therapeutics, Inc. (3)
- INTREXON CORP (19)
- Intrinsic Medicine, Inc. (1)
- IO Biotech, Inc. (2)
- IONIS PHARMACEUTICALS INC (29)
- IRONWOOD PHARMACEUTICALS INC (4)
- iTeos Therapeutics, Inc. (2)
- Janux Therapeutics, Inc. (1)
- Keros Therapeutics, Inc. (1)
- Kezar Life Sciences, Inc. (1)
- Kindred Biosciences, Inc. (1)
- Kiromic Biopharma, Inc. (2)
- Kronos Bio, Inc. (1)
- Kura Oncology, Inc. (1)
- Kymera Therapeutics, Inc. (4)
- LEAP THERAPEUTICS, INC. (2)
- LEXICON PHARMACEUTICALS, INC. (8)
- LianBio (6)
- Ligand Pharmaceuticals Incorporated (2)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
- Locust Walk Acquisition Corp. (1)
- LogicBio Therapeutics, Inc. (1)
- Lyell Immunopharma, Inc. (3)
- MACROGENICS INC (3)
- MADRIGAL PHARMACEUTICALS, INC. (3)
- Magenta Therapeutics, Inc. (8)
- MANNKIND CORP (3)
- MeiraGTx Holdings plc (2)
- Mersana Therapeutics, Inc. (17)
- Merus N.V. (1)
- MIRAGEN THERAPEUTICS, INC. (11)
- Mirati Therapeutics, Inc. (4)
- Moderna, Inc. (2)
- Molecular Templates, Inc. (5)
- Momenta Pharmaceuticals, Inc. (6)
- Monte Rosa Therapeutics, Inc. (2)
- Morphic Holding, Inc. (9)
- MYMETICS CORP (2)
- Myriad Genetics, Inc. (1)
- NEUROBIOLOGICAL TECHNOLOGIES INC (2)
- NEUROCRINE BIOSCIENCES INC (9)
- NEUROTROPE BIOSCIENCE, INC. (1)
- NEWLINK GENETICS CORP (7)
- NextCure, Inc. (2)
- Nkarta, Inc. (3)
- NOVAVAX INC (5)
- Nuo Therapeutics, Inc. (1)
- Nurix Therapeutics, Inc. (9)
- Olema Pharmaceuticals, Inc. (4)
- Olivia Ventures, Inc. (2)
- OncoCyte Corp (1)
- ONCOSEC MEDICAL Inc (1)
- Opko Health, Inc. (2)
- ORAGENICS INC (8)
- ORGANOVO HOLDINGS, INC. (1)
- Orgenesis Inc. (2)
- Oric Pharmaceuticals, Inc. (1)
- Ovid Therapeutics Inc. (3)
- Pasithea Therapeutics Corp. (4)
- Passage BIO, Inc. (12)
- PDL BIOPHARMA, INC. (1)
- PharmaCyte Biotech, Inc. (1)
- PIERIS PHARMACEUTICALS, INC. (16)
- PORTOLA PHARMACEUTICALS INC (3)
- Poseida Therapeutics, Inc. (2)
- Praxis Precision Medicines, Inc. (1)
- PRECISION BIOSCIENCES INC (4)
- Prometheus Biosciences, Inc. (1)
- Protagonist Therapeutics, Inc (6)
- PROTEOSTASIS THERAPEUTICS, INC. (6)
- PTC THERAPEUTICS, INC. (5)
- PUMA BIOTECHNOLOGY, INC. (1)
- Pyxis Oncology, Inc. (1)
- RAPT Therapeutics, Inc. (4)
- RECURSION PHARMACEUTICALS, INC. (4)
- Regeneron Pharmaceuticals (19)
- REGENXBIO Inc. (1)
- Regulus Therapeutics Inc. (4)
- Relay Therapeutics, Inc. (4)
- RenovaCare, Inc. (1)
- Repare Therapeutics Inc. (9)
- Replimune Group, Inc. (2)
- Retrophin, Inc. (2)
- REXAHN PHARMACEUTICALS, INC. (5)
- Rezolute, Inc. (2)
- Rich Pharmaceuticals, Inc. (2)
- RIGEL PHARMACEUTICALS INC (5)
- Sage Therapeutics, Inc. (1)
- SANGAMO THERAPEUTICS, INC (12)
- Sarepta Therapeutics, Inc. (15)
- Savara Inc (3)
- Scholar Rock Holding Corp (1)
- SEATTLE GENETICS INC (19)
- SERA PROGNOSTICS, INC. (1)
- Seres Therapeutics, Inc. (3)
- Sesen Bio, Inc. (1)
- Shattuck Labs, Inc. (2)
- Sigilon Therapeutics, Inc. (2)
- Silverback Therapeutics, Inc. (2)
- Solid Biosciences Inc. (1)
- SOLIGENIX, INC. (3)
- Sorrento Therapeutics, Inc. (1)
- SpringWorks Therapeutics, Inc. (3)
- SQZ Biotechnologies Co (2)
- SUNESIS PHARMACEUTICALS INC (3)
- SUTRO BIOPHARMA, INC. (3)
- Syndax Pharmaceuticals Inc (5)
- SYNLOGIC, INC. (2)
- Synthetic Biologics, Inc. (5)
- Syros Pharmaceuticals, Inc. (3)
- T2 Biosystems, Inc. (3)
- Taysha Gene Therapies, Inc. (2)
- TG THERAPEUTICS, INC. (1)
- Tonix Pharmaceuticals Holding Corp. (1)
- Tracon Pharmaceuticals, Inc. (1)
- Translate Bio, Inc. (3)
- TScan Therapeutics, Inc. (2)
- Turning Point Therapeutics, Inc. (1)
- Ultragenyx Pharmaceutical Inc. (18)
- uniQure N.V. (3)
- United Therapeutics Corp (1)
- Unum Therapeutics Inc. (1)
- VACCINEX, INC. (1)
- Vaccitech plc (1)
- VBI Vaccines Inc (5)
- Verastem, Inc. (2)
- Verve Therapeutics, Inc. (1)
- VICAL INC (2)
- Viela Bio, Inc. (1)
- Vir Biotechnology, Inc. (17)
- VistaGen Therapeutics, Inc. (3)
- Voyager Therapeutics, Inc. (3)
- Werewolf Therapeutics, Inc. (1)
- WINDTREE THERAPEUTICS INC (6)
- Xencor Inc (8)
- Xenetic Biosciences, Inc. (1)
- Xenon Pharmaceuticals Inc. (2)
- XOMA Corp (8)
- YIELD10 BIOSCIENCE, INC. (1)
- Zai Lab Ltd (6)
- ZIOPHARM ONCOLOGY INC (1)
- Zymeworks Inc. (3)
- Collaboration and Option Agreement by and between Senti Biosciences, Inc., and Celest Therapeutics (Shanghai) Co. Ltd., dated November 6, 2023 (Dynamics Special Purpose Corp., Filed With SEC on March 21, 2024)
- Research Collaboration and Co-Development Agreement, dated as of November 9, 2022, by and between Nextcure, Inc. and LegoChem Biosciences, Inc (NextCure, Inc., Filed With SEC on March 21, 2024)
- Strategic Collaboration Agreement, dated January 3, 2024, by and between Foresight Diagnostics, Inc. and the Registrant (Allogene Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Amended and Restated Collaboration and License Agreement, dated January 17, 2024, by and between the Registrant and Notch Therapeutics Inc (Allogene Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Strategic Collaboration and License Agreement, dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Entrada Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Amendment No. 2, dated February 1, 2024, to the Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT... (RAPT Therapeutics, Inc., Filed With SEC on March 7, 2024)
- First Amendment to the Collaboration and License Agreement, dated November 7, 2023, by and among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Poseida Therapeutics, Inc., Filed With SEC on March 7, 2024)
- Letter Agreement Terminating Development Collaboration and License Agreement between registrant and Socit des Produits Nestl S.A. (f/k/a NESTEC S.A.), dated October 26, 2023 (DBV Technologies S.A., Filed With SEC on March 7, 2024)
- First Amendment to the Amended and Restated License and Collaboration Agreement, dated June 14, 2023, by and between Inovio Pharmaceuticals, Inc. and Beijing Apollo Saturn... (INOVIO PHARMACEUTICALS, INC., Filed With SEC on March 6, 2024)
- Amended and Restated Research Collaboration and Option Agreement by and between Bayer AG and the Registrant, dated November 8, 2023 (RECURSION PHARMACEUTICALS, INC., Filed With SEC on February 29, 2024)
- Amendment no. 14 dated October 31, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Sarepta Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Amendment no. 13 dated August 31, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Sarepta Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Amendment no. 12 dated July 28, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Sarepta Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Amendment no. 11 dated June 23, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Sarepta Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Amendment No. 1 Collaboration and License Agreement between the Registrant and Gilead Sciences, Inc (Arcellx, Inc., Filed With SEC on February 28, 2024)
- License and Collaboration Agreement by and between Registrant and Novartis Pharma AG, dated December 28, 2023 (Voyager Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Research Collaboration and License Agreement, dated November 27, 2023, by and between Bristol-Myers Squibb Company and the Registrant (Avidity Biosciences, Inc., Filed With SEC on February 28, 2024)
- License and Collaboration Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics (MANNKIND CORP, Filed With SEC on February 27, 2024)
- Amendment 03 to Collaboration and Option Agreement, dated November 30, 2023, by and between the Registrant and Ono Pharmaceutical Co. Ltd (FATE THERAPEUTICS INC, Filed With SEC on February 26, 2024)
- Amendment No. 3 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated January 2 (Arcus Biosciences, Inc., Filed With SEC on February 21, 2024)
- Clinical Trial Collaboration and Supply Agreement by and between Gilead Sciences, Inc. and IDEAYA Biosciences, Inc. dated as of November 29, 2023 (IDEAYA Biosciences, Inc., Filed With SEC on February 20, 2024)
- Fifth Amendment to Collaboration and License Agreement, dated November 3, 2023, by and between the Registrant and Genzyme Corporation (Nurix Therapeutics, Inc., Filed With SEC on February 15, 2024)
- Amendment 1 to the Master Research Collaboration Agreement, dated November 29, 2023, by and between Neurogene Inc. and The University Court of The University of Edinburgh (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on December 19, 2023)
- Collaboration and Option Agreement, dated August 12, 2022, by and between Q32 Bio Inc. and Horizon Therapeutics Ireland DAC (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
- Form of Collaboration Agreement (PharmaCyte Biotech, Inc., Filed With SEC on November 16, 2023)
- Amended and Restated Collaboration and License Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (VBI Vaccines Inc, Filed With SEC on November 14, 2023)
- Collaboration and License Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (VBI Vaccines Inc, Filed With SEC on November 14, 2023)
- Amendment Number One to Collaboration and License Agreement, dated August 3, 2023, by and between Arcturus Therapeutics, Inc. and Seqirus Inc (Arcturus Therapeutics Holdings Inc., Filed With SEC on November 14, 2023)
- Amendment No. 1, dated September 12, 2023, to the Amended and Restated License and Collaboration Agreementby and between the Registrant and Seagen Inc (PIERIS PHARMACEUTICALS, INC., Filed With SEC on November 14, 2023)
- Collaboration and License Agreement, by and between the Company and Everest Medicines II (HK) Limited, dated as of September 20, 2023 (Kezar Life Sciences, Inc., Filed With SEC on November 13, 2023)
- Amendment No. 5 to Master Collaboration Agreement, by and between the Company and FUJIFILM Cellular Dynamics Inc., dated September 22, 2023 (Century Therapeutics, Inc., Filed With SEC on November 9, 2023)
- Amendment Number Two to the Collaboration Agreement by and between the Company and Adimab, LLC, dated September 19, 2023 (Adagio Therapeutics, Inc., Filed With SEC on November 9, 2023)
- Collaboration and License Agreement between Monte Rosa Therapeutics AG, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated as of October 16, 2023 (Monte Rosa Therapeutics, Inc., Filed With SEC on November 9, 2023)
- Third Amendment to License and Collaboration Agreement by and between Registrant and Regeneron Pharmaceuticals, Inc., dated September 29, 2023 (Intellia Therapeutics, Inc., Filed With SEC on November 9, 2023)
- Letter Agreement (Second Amendment) to License and Collaboration Agreement by and between Registrant and Regeneron Pharmaceuticals, Inc., dated November 22, 2022 (Intellia Therapeutics, Inc., Filed With SEC on November 9, 2023)
- Amendment to Pilot Collaboration and Option Agreement, dated as of August 16, 2023, among Synlogic Operating Company, Inc. and Hoffman-La Roche Inc (SYNLOGIC, INC., Filed With SEC on November 9, 2023)
- Amendment No. 1 to Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc and the Netherlands Cancer Institute, Amsterdam, and the Oncode Institute,... (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on November 9, 2023)
- Amendment No. 1 to the Research Collaboration and License Agreement (effective February 2, 2022), dated July 14, 2023, by and between Mersana Therapeutics, Inc. and Janssen... (Mersana Therapeutics, Inc., Filed With SEC on November 7, 2023)
- Amendment No. 1 to the License and Collaboration Agreement (RIGEL PHARMACEUTICALS INC, Filed With SEC on November 7, 2023)
- Collaboration Agreement, dated October 31, 2023, by and between Synaptogenix, Inc. and Cannasoul Analytics Ltd (NEUROTROPE BIOSCIENCE, INC., Filed With SEC on November 6, 2023)